Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: Incidence and underlying genetic abnormalities

Leukemia

Volumn 17, Issue 6, 2003, Pages 1124-1129

  Primo, D ^a,c   Tabernero, M D ^a   Rasillo, A ^a,c   Sayagues J M ^a,c   Epinosa, A B ^a,c   Chillon M C ^a   Garcia Sanz, R ^a   Gutierrez, N ^a   Giralt, M ^d   Hagemeijer, A ^e   San Miguel, J F ^a,c   Orfao, A ^a,b,c  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ALL; AML; BCR ABL; CML; FISH; Ph chromosome

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME 22; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME LOSS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; GENE REARRANGEMENT; GENETIC DISORDER; HUMAN; INCIDENCE; INTERPHASE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; METAPHASE; MONOSOMY; NUMERICAL CHROMOSOME ABERRATION; PHILADELPHIA 1 CHROMOSOME; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SUPERNUMERARY CHROMOSOME;

EID: 0037702852     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402963     Document Type: Article

References (26)

1. Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-293.
2. Bartram CR, Carbonell F. bcr rearrangement in Ph-negative CML. Cancer Genet Cytogenet 1986; 21: 183-184.
3. Ganesan TS, Rassool F, Guo AP, Th'ng KH, Dowding C, Hibbin JA et al. Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood 1986; 68: 957-960.
4. Shtalrid M, Talpaz M, Blick M, Romero P, Kantarjian H, Taylor K et al. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy. J Clin Oncol 1988; 6: 1569-1575.
5. Secker-Walker LM. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 49: 1-13.
6. Melo JV. The molecular biology of chronic myeloid leukaemia. Leukemia 1996; 10:751-756.
7. Garcia-Isidoro M, Tabernero MD, Garcia JL, Najera ML, Hernandez JM, Wiegant J et al. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection. Hum Pathol 1997; 28: 154-159.
8. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95: 738-743.
9. Dewald GW, Wyatt WA, Juneau AL, Carlson RO, Zinsmeister AR, Jalal SM et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998; 91: 3357-3365.
10. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P et al. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994; 83: 1922-1928.
11. Dewald GW, Wyatt WA, Silver RT. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymph 1999; 34: 481-491.
12. Rieder H, Bonwetsch C, Janssen LA, Maurer J, Janssen JW, Schwartz S et al. High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia. Leukemia 1998; 12: 1473-1481.
13. Herens C, Tassin F, Lemaire V, Beguin Y, Collard E, Lampertz S et al. Deletion of the 5′-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. Br J Haematol 2000; 110: 214-216.
14. Huntly BJ, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P et al. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 98: 1732-1738.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick H et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994; 87: 746-754.
16. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
17. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783-1786.
18. Hernandez JM, del Canizo MC, Cuneo A, Garcia JL, Gutierrez NC, Gonzalez M et al. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. Ann Oncol 2000; 11: 441-444.
19. Maillo A, Diaz P, Sayagues JM, Blanco A, Tabernero MD, Ciudad J et al. Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer. 2001; 92: 377-385.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
21. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928.
22. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 1987; 83: 445-454.
23. Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S et al. Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 1991; 78: 2411-2418.
24. van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 1996; 87: 5213-5217.
25. Williams BG, Yin JL, Ma DD. A Ph+acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts. Leuk Lymph 1994; 14: 341-346.
26. Abruzzese E, Pettenati MJ, Cox K, Jackle B, Watts RG, Carroll AJ et al. Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases. Cancer Genet Cytogenet 1998; 105: 164-167.